Showing results (1191-1200 of 1,396) with videos related to
Sort By:
Pageof 140
JCO Precision Oncology|December 5, 2025
Impact of SPOP Mutations on Clinical Outcomes in Metastatic Prostate CancerDeepak Kilari, Nicholas C Henderson, Kyra Yamamoto, et al.JCO Precision Oncology|December 5, 2025
Clinical Presentation of MTAP Deletions in Real-World Settings: Lessons for the Clinical Development of Novel Targeted TherapiesJordan T Best, Xiaotong Fu, Sripraharsha S Jampana Raju, et al.JCO Precision Oncology|September 24, 2025
Clinical and Pathologic Landscapes of Delta-Like Ligand 3 and Seizure-Related Homolog Protein 6 Expression in Neuroendocrine CarcinomasJessica S Ross, Rohit Thummalapalli, Kristine Lacuna, et al.JCO Precision Oncology|September 24, 2025
Longitudinal Evaluation of Circulating Tumor DNA as a Prognostic Biomarker to Detect Molecular Residual Disease in Germ Cell TumorsRebecca Hassoun, Reuben Ben-David, John P Sfakianos, et al.JCO Precision Oncology|September 26, 2025
Immune and Genomic Heterogeneity of MET-Altered Non-Small Cell Lung CancerManlu Liu, Rachel L Minne, Saahil Javeri, et al.JCO Precision Oncology|September 17, 2025
Optimized Biopsy Strategy for Transition Zone Prostate Cancer With Enhanced Perilesional Sampling: A Retrospective Analysis and Clinical Trial ValidationXin Chen, Chen Huang, Chenchao Zhou, et al.JCO Precision Oncology|September 10, 2025
Germline Findings From Tumor-Only Comprehensive Genomic Profiling in the RATIONAL Study: A Missed Opportunity?Riziero Esposito Abate, Alessandro Morabito, Michele Milella, et al.JCO Precision Oncology|September 24, 2025
Histologic Subvariants of Retroperitoneal Well-Differentiated Liposarcoma Show Evidence of Clinical and Genomic Progression Toward Dedifferentiated LiposarcomaGeorge Z Li, Jay Lee, Karissa Whiting, et al.JCO Precision Oncology|August 1, 2025
Prognostic Indicators of Preoperative Fluorouracil, Leucovorin, Oxaliplatin, and Docetaxel Efficacy in Locally Advanced Gastroesophageal and Gastric Cancer: Integrating Biomarker Analysis and Clinicopathological FactorsAmane Jubashi, Izuma Nakayama, Naoya Sakamoto, et al.JCO Precision Oncology|August 1, 2025
Using Dose-Escalation and -Expansion Cohort Study as Pivotal Trial for Targeted Anticancer Drug ApprovalYafang Huang, Ting Zhu, Jinjia Zhong, et al.Pageof 140